Systemic Lupus Erythematosus  >>  AMG 811  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AMG 811 / Amgen
NCT00818948: Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis

Checkmark Patients with systemic lupus erythematosus and lupus nephritis
Aug 2015 - Aug 2015: Patients with systemic lupus erythematosus and lupus nephritis
Completed
1b
56
US, Europe, RoW
AMG 811
Amgen
Nephritis, Systemic Lupus Erythematosus
06/14
08/14
NCT02291588: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus

Completed
1
26
US
AMG 811, Placebo
Amgen
Systemic Lupus Erythematosus
03/10
06/10
NCT01164917: Safety Study of AMG 811 in Subjects With Discoid Lupus Erythematosus

Checkmark Systemic Lupus Erythematosus - ACR/ARHP 2013
Sep 2013 - Sep 2013: Systemic Lupus Erythematosus - ACR/ARHP 2013
Checkmark LUPUS 2013
Mar 2013 - Mar 2013: LUPUS 2013
Terminated
1
16
US
AMG811, AMG811 Placebo
Amgen
Cutaneous Lupus, Discoid Lupus, Lupus, Systemic Lupus Erythematosus
09/12
03/13

Download Options